The abnormal appearance of the tablets does not meet the product’s quality requirements and may lead to interruption of pharmacotherapy, which in turn may pose a risk to patients’ life or health. Potential effects: worsening of the disease, complications, risk to life or health.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Arpixor tablets from batch P1 with expiry date 06.2023; patients should check the batch number and, if they have this product, contact a pharmacist or doctor to return it and arrange approp...
The Chief Pharmaceutical Inspector withdrew batch P1 of Arpixor from the market throughout the country and granted the decision immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related